Professor, Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center

Speciality Interests

Aplastic anemia, ITP, myelodysplastic syndrome, acute leukemia, MPN

Schedule

schedule of week
05 MON
06
TUE
07
WEN
08
THU
09
FRI
10
AM available available
PM available

Medical School

2000~2002 Ph.D. in Medicine Graduate School, Yonsei University, Korea 1998~2000 Master of Science Graduate School, Yonsei University, Korea 1986~1992 College of Medicine, Yonsei University, Korea

Specialty Training

Specialty Training
Fellowship   2002~2004 University of Michigan Ann Arbor, USA
2000~2002 Hematology-Oncology, Severance Hospital, College of Medicine Yonsei University, Korea
Residency   1999~2002 Internal Medicine, Severance Hospital, College of Medicine Yonsei University, Korea
Internship   1995~1996 Severance Hospital, College of Medicine Yonsei University, Korea

Other Education

  • 2014~present Professor Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center
    2013~2015 Chief Division of Hematology-Oncology, Samsung Medical Center
    2007~2013 Associate Professor Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center
    2004~2007 Clinical Instructor Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea

Participation in Academic Societies
and Research

  • 2022~Present Director The Korean Society of blood transfusion
    2019~Present Chairman of the commission The Korean Society of Hematology aplastic anemia working Party
    2014~Present Director The Korean Society for patient blood management
    2010~Present Member The Korean Association of internal medicine
    2007~Present Member The Korean Society of Blood and marrow transplantation
    1998~Present Member The Korean Society of Hematology
    2000~Present Member The American Society of Hematology
    2000~Present Member The European Hematology Association

Thesis

ASIA-PAC J CLIN ONCO 2021 10.1111/ajco.13609

Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Kobayashi1, Y; Oh, I; Miyamoto, T; Lee, WS; Iida, H; Minami, H; Maeda, Y; Jang, JH; Yoon, SS; Yeh, SP; Tran, Q; Morris, J; Franklin, J; Kiyoi, H

ANN LAB MED 2021 10.3343/alm.2021.41.3.342

LSAMP Rearrangement in Acute Myeloid Leukemia With a Jumping Translocation Involving 3q13.31

Yoon1, J; Cho, EH; Yun, JW; Kim, HY; Jang, JH; Kim, HJ; Kim, SH

KOREAN J INTERN MED 2021 10.3904/kjim.2019.385

Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome

Jung1, HA; Jung, CW; Jang, JH

J CLIN ONCOL 2021 10.1200/JCO.20.01895

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

Steensma1, DP; Fenaux, P; Van Eygen, K; Raza, A; Santini, V; Germing, U; Font, P; Diez-Campelo, M; Thepot, S; Vellenga, E; Patnaik, MM; Jang, JH; Varsos, H; Bussolari, J; Rose, E; Sherman, L; Sun, LB; Wan, Y; Dougherty, S; Huang, F; Feller, F; Rizo, A; Platzbecker, U

BRIT J HAEMATOL 2021 10.1111/bjh.17190

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study

Jang1, JH; Tomiyama, Y; Miyazaki, K; Nagafuji, K; Usuki, K; Uoshima, N; Fujisaki, T; Kosugi, H; Matsumura, I; Sasaki, K; Kizaki, M; Sawa, M; Hidaka, M; Kobayashi, N; Ichikawa, S; Yonemura, Y; Enokitani, K; Matsuda, A; Ozawa, K; Mitani, K; Lee, JW; Nakao, S

CLOSE

Patients' Rights and Responsibilities

Patients' Rights

1. Right to receive medical care

Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

2. Right to be informed and to make an autonomous decision

Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

3. Right to confidentiality

Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

4. Right to request consultation and mediation

In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

5. Right to have values and beliefs respected

Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

6. Right to receive care in a safe setting

Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

Patients' Responsibilities

1. Responsibility to trust and respect the medical team

Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

2. Responsibility to not use dishonest methods for medical treatment

Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

3. Responsibility to abide by all hospital regulations

Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.